Skip to main content
. 2023 Jun 26;14(10):1913–1919. doi: 10.7150/jca.84261

Table 3.

Association between IMDC outcomes and CRP levels before and after treatment

Characteristic N Initial CRP
Median (IQR)
p value N Post-treatment CRP
Median (IQR)
p value
Clinical remission 0.146 0.680
Yes 54 27.5 (9.4-59.5) 84 3.5 (1.2-13.5)
No 15 14.5 (7.8-32.3) 18 4.1 (1.0-10.7)
Endoscopic remission 0.884 0.063
Yes 18 20.7 (8.6-59.5) 32 2.2 (0.6-7.2)
No 12 20.0 (8.7-49.3) 23 4.0 (2.0-10.3)
Histologic remission 0.613 0.143
Yes 14 18.1 (12.1-40.0) 24 2.0 (0.6-6.2)
No 18 27.8 (8.6-69.0) 33 3.8 (1.9-9.1)
Symptom recurrence 0.310 0.512
Yes 18 27.5 (15.2-55.4) 29 3.8(1.6-17.5)
No 52 17.9 (7.4-45.8) 72 3.5(1.0-10.9)

Footnote: Mann-Whitney U test was used and reported as median and IQR.